Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Werewolf Therapeutics Inc (HOWL)

Werewolf Therapeutics Inc (HOWL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 243,177
  • Shares Outstanding, K 43,347
  • Annual Sales, $ 19,940 K
  • Annual Income, $ -37,370 K
  • 60-Month Beta 0.70
  • Price/Sales 11.93
  • Price/Cash Flow N/A
  • Price/Book 1.52
Trade HOWL with:

Options Overview Details

View History
  • Implied Volatility 171.80% ( +36.87%)
  • Historical Volatility 72.10%
  • IV Percentile 90%
  • IV Rank 44.47%
  • IV High 311.96% on 11/02/23
  • IV Low 59.54% on 07/18/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 14
  • Volume Avg (30-Day) 32
  • Put/Call OI Ratio 1.20
  • Today's Open Interest 673
  • Open Int (30-Day) 604

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.35
  • Number of Estimates 4
  • High Estimate -0.28
  • Low Estimate -0.41
  • Prior Year -0.34
  • Growth Rate Est. (year over year) -2.94%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.50 +29.78%
on 04/12/24
6.74 -13.35%
on 04/01/24
-0.30 (-4.89%)
since 03/15/24
3-Month
3.86 +51.30%
on 01/23/24
8.19 -28.73%
on 02/26/24
+1.13 (+23.99%)
since 01/17/24
52-Week
1.57 +271.15%
on 10/24/23
8.19 -28.73%
on 02/26/24
+3.35 (+134.54%)
since 04/17/23

Most Recent Stories

More News
Werewolf Therapeutics, Inc. (HOWL) Reports Q1 Loss, Tops Revenue Estimates

Werewolf Therapeutics, Inc. (HOWL) delivered earnings and revenue surprises of 30.61% and 46.36%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?...

HOWL : 5.84 (+4.10%)
THMO : 0.6300 (-10.14%)
Werewolf Therapeutics, Inc. (HOWL) Reports Q4 Loss, Tops Revenue Estimates

Werewolf Therapeutics, Inc. (HOWL) delivered earnings and revenue surprises of 33.90% and 131.21%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the...

HOWL : 5.84 (+4.10%)
HUMA : 3.12 (+1.96%)
New Strong Buy Stocks for January 20th

NBSE, PRTG, RELL, HOWL and PATH have been added to the Zacks Rank #1 (Strong Buy) List on January 20, 2022.

RELL : 9.86 (-0.40%)
PATH : 19.12 (-1.49%)
NBSE : 0.4199 (+4.45%)
PRTG : 0.2212 (-21.28%)
HOWL : 5.84 (+4.10%)
New Strong Buy Stocks for January 18th

DTEGY, CYN, OKTA, HOWL and ONCY have been added to the Zacks Rank #1 (Strong Buy) List on January 18, 2022.

DTEGY : 22.1700 (+0.54%)
CYN : 0.1022 (+1.49%)
ONCY : 1.0400 (-3.70%)
OKTA : 93.80 (-1.27%)
HOWL : 5.84 (+4.10%)
Werewolf Therapeutics, Inc. (HOWL) Reports Q3 Loss, Misses Revenue Estimates

Werewolf Therapeutics, Inc. (HOWL) delivered earnings and revenue surprises of 33.33% and 18.53%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the...

HOWL : 5.84 (+4.10%)
HOOK : 0.7625 (-5.85%)
Here's Why You Should Consider Investing in JAZZ Stock Now

JAZZ's new drugs like Xywav, Rylaze and Zepzelca, along with the recently-acquired drugs, are expected to generate 65% of product revenues in 2022.

JAZZ : 107.10 (-1.65%)
AXSM : 69.71 (+1.31%)
SWTX : 44.11 (+1.64%)
HOWL : 5.84 (+4.10%)
Werewolf Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Highlights

- FDA granted IND clearance for lead candidate WTX-124 for evaluation as a treatment for advanced solid tumors - - Submission of IND application for...

HOWL : 5.84 (+4.10%)
JAZZ's Late-Stage Multiple Sclerosis Study on Nabiximols Fails

JAZZ's phase III study evaluating nabiximols oromucosal spray for clinical measures of spasticity in multiple sclerosis patients fails to meet the primary endpoint.

JAZZ : 107.10 (-1.65%)
AXSM : 69.71 (+1.31%)
ASRT : 0.7800 (-1.97%)
HOWL : 5.84 (+4.10%)
Werewolf Therapeutics to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference

CAMBRIDGE, Mass., June 06, 2022 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative...

HOWL : 5.84 (+4.10%)
Werewolf Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Highlights

- Entered exclusive global license and collaboration agreement with Jazz Pharmaceuticals to develop and commercialize WTX-613; received $15.0M upfront...

HOWL : 5.84 (+4.10%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Werewolf Therapeutics Inc. is a biopharmaceutical company. It involved in the development of conditionally activated therapeutics engineered to stimulate the body's immune system for the treatment of cancer. Werewolf Therapeutics Inc. is based in CAMBRIDGE, Mass.

See More

Key Turning Points

3rd Resistance Point 6.56
2nd Resistance Point 6.30
1st Resistance Point 6.07
Last Price 5.84
1st Support Level 5.58
2nd Support Level 5.32
3rd Support Level 5.09

See More

52-Week High 8.19
Last Price 5.84
Fibonacci 61.8% 5.66
Fibonacci 50% 4.88
Fibonacci 38.2% 4.10
52-Week Low 1.57

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar